Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not everyday do you see a Share rise like this, so it forced me to research a little.
The appointment of Chris Wardhaugh as stated in the RNS is critical for this to succeed. For those who do not know him, research his achievements. Some of them include:
Cheif Business Officer for MGB Biopharma - which is a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance.
Why is this important? - because Iclaprim which is in its phase III is an anti-biotic that treats skin diseases - it has reached 'Orphan status' in the U.S which is pretty big.
So why was he appointed by MGB Biopharma? - because they were in preparing to start PHASE II trial of MGB-BP-3 to assess the initial cure and sustained cure rates in the treatment of Clostridium difficile-associated diarrhoea (CDAD).
Why is this important - because Iclaprim is in the PHASE II/III stages and this guy has the experience and knowledge.
So what happened to that anti-infective medication - The company suddenly goes on to succeeding and getting it approved.
To cut the story short, and to save the best to last, the guy specialises in Company acquisitions and has bloody overseen the launch of 8 pharmaceutical products around the world. So everyone is in good hands. In fact, I might even join you guys in this.
Full info:
CHRIS WARDHAUGH has over 25 years of experience in the Life Science Sector including being Senior Director of Global Partnering of Quintiles and Head of Business Development and Operations Director of Prostrakan, among others. Most recently, Chris has been Senior Executive Advisor for Nanogenics, Senior Advisor for Clyde Biosciences and the Founder of Sercader Limited and previously he was Chief Operating Officer and President of Clyde Biosciences.
Mr Wardhaugh’s has significant transaction experience, including company acquisitions, funding rounds, market entries and IPOs. He has also overseen the launch of 8 pharmaceutical products (such as Tostran, Abstral, Rectogesic) in the USA, UK, Germany, France, Italy, Spain, The Netherlands, Belgium, and others.
https://www.mgb-biopharma.com/mgb-biopharma-expands-management-team-with-appointment-of-chris-wardhaugh-as-chief-business-officer/
Well done MAFs . It was a dog with no legs and is now a dachshund with little ones . Let’s hope they are not too little to climb the stairs tomorrow
Can’t believe I went back on this after suffering in the valentine day massacre . But it’s a strange market at the moment and strange things are happening . Bet the FDA would pass it now in this climate
What are people’s honest opinions on the value of him joining the board? In MCAP/SP terms? I’ve been spiked so many times and if I come in here I don’t want to be spiked but think there’s more behind this mega rise
don't go in then but if you do look at cash shells and reverse takeovers ( what they mean) before you do. ( youtube is good for this )
Thank you cadellin
no problem don't forget it is your money ( don't part with it unless you can afford to lose it ) but look at reverse takeover explained
It was really difficult to buy or sell anything towards the end of the day. Buying pressure was intense going into the close Sam. Might bode well for tomorrow morning. As the rest have mentioned, have a look at RTOs.
Sam, all I will say is people chase rainbows and sometimes get caught out, and other times sit on the sidelines asking others what to do and miss the boat. The best advice is to do your own research, and follow your own gut feeling. I’ve done that here with this share, and I personally believe it’s got more legs than a millipede. Good luck with whatever you choose to do, but be sure to follow your own beliefs.
Amazing post and sound advice, I cottoned on to the dots 1st thing, have a little conviction on why you bought into the concept and stick with it.
Thank you pokerock and mojo been a great day for all and hopefully if I do decide to buy in it continues and I don’t ruin it for everyone like normal haha
I'm thinking Facebook rise here. I advised but got chastised. It's a bet but just if ...just imagine you are right on a scary bet...if imright 50% of profits going to local hospice care. Maybe more
You have been asserting 20p all day. You must know something we don't know MrNation.